Basal Ganglia Pathophysiology
61 – 70 of 200
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Dramatic differences in susceptibility to L-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion
- Contribution to journal › Article
-
Mark
Oral and infusion levodopa therapy in the management of Parkinson’s disease
(2016) p.63-75
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Signaling mechanisms in L-DOPA-induced dyskinesia
(2016) p.155-188
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Endogenous and treatment-induced neuroplasticity in mouse models of Parkinson's disease
(2016)
- Thesis › Doctoral thesis (compilation)
-
Mark
Validation of an improved scale for rating L-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists
- Contribution to journal › Article
- 2015
-
Mark
Zooming in on the small: The plasticity of striatal dendritic spines in l-DOPA-Induced dyskinesia.
- Contribution to journal › Article
-
Mark
Rodent models of impulsive compulsive behaviors in Parkinson's disease: how far have we reached?
- Contribution to journal › Scientific review
-
Mark
M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia.
- Contribution to journal › Article
-
Mark
Increased CSF biomarkers of angiogenesis in Parkinson disease.
- Contribution to journal › Article
-
Mark
Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and l-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist.
- Contribution to journal › Article
